New imaging technology to study RNA activity in cancer cells

In situ assay imaging nuclear RNA exosome activity for cancer studies

NIH-funded research Baylor College of Medicine · NIH-10682455

This study is testing a new imaging technology that helps us see how cancer cells break down RNA, which could give us important clues about how these cells grow and react to treatments, making it easier to understand and fight cancer.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionBaylor College of Medicine NIH-funded
Lab location1 site (Houston, United States)
Project IDNIH-10682455 on NIH RePORTER

What this research studies

This research focuses on developing a groundbreaking imaging technology that can visualize the activity of nuclear RNA exosomes in cancer cells. By labeling RNA degradation processes, this innovative approach aims to provide insights into how cancer cells proliferate and respond to treatments. The technology will allow for detailed assessments of tumor cell stress and the effectiveness of anticancer therapies, which are crucial for understanding cancer biology. This method is expected to improve upon traditional biochemical approaches that often overlook the complexity of heterogeneous tissue samples.

Who could benefit from this research

Good fit: Ideal candidates for this research are patients diagnosed with various types of cancer who are undergoing treatment or evaluation.

Not a fit: Patients with non-cancerous conditions or those not currently receiving cancer treatment may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective cancer treatments by providing a better understanding of RNA metabolism in tumors.

How similar studies have performed: While the approach is innovative, similar imaging technologies have shown promise in other areas of cancer research, indicating potential for success.

Where this research is happening

Houston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Anti-Cancer AgentsCancer DrugNeoplastic Disease Chemotherapeutic Agentsanti-cancer druganticancer agent
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.